Tivanisiran sodium (SYL1001 sodium) is a small interfering RNA (siRNA) targeting TRPV1 . Tivanisiran sodium induces the degradation of TRPV1 mRNA, thereby inhibiting protein synthesis. Tivanisiran sodium alleviates ocular discomfort and pain, and improves ocular hyperemia and tear quality. Tivanisiran sodium is applicable to research related to dry eye disease[1][2].
Molecular Weight:
12068.3 (free acid)
Purity:
96.85
CAS Number:
[1848239-71-3]
Formula:
C361H411N141O262Na36P36
Target:
Small Interfering RNA (siRNA),TRP Channel
Application Notes:
MCE Product type: Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted